Pancreatic cancer is characterized by numerous genetic and epigenetic alterations [1, 2] 
actin-binding protein family. ERM proteins act as linkers between the actin cytoskeleton and the plasma membrane
, and regulate cell morphology, motility and other processes that are implicated in tumourigenesis [7] . The structural-functional role of moesin has been assessed in epithelial cell polarity and cortical actin congregation [8, 9] . Moesin has also been implicated in epithelial-tomesenchymal transition (EMT) [7] . Previously, expression of ezrin has been associated with the aggressiveness of pancreatic and endometrial cancers [10] [11] [12] , and enhanced expression of ezrin/radixin/moesin has been associated with poor survival of pancreatic cancer patients [13, 14] . In contrast, another family member, merlin, has been identified as a tumour suppressor [15, 16] . Nevertheless, ERM proteins are considered to be functionally redundant when co-expressed in mammalian cells [17] , and there are insufficient data regarding the specific role of moesin in carcinogenesis.
Materials and methods

Patients and tissue collection
Seventy PDAC and eight PAC tissue samples were obtained from patients (median age 62.5 years; range 41-78) who underwent pancreatic resections at the University Hospital of Heidelberg (Germany). Ten normal human pancreatic tissue samples were obtained from previously healthy individuals through an organ donor program (median age 45 years; range 20-74 years). All studies were approved by the Ethics Committee of the University of Heidelberg. Written informed consent was obtained from all patients.
Cell culture
Pancreatic cancer cell lines: Aspc1, BxPc3, Capan1, Colo375, MiaPaca2, Panc-1, SU8686 and T3M4 were routinely grown in RPMI medium supplemented with 10% foetal calf serum (FCS), 100 U/ml penicillin, and 100 g/ml streptomycin. Cells were maintained at 37ЊC in a humid chamber with 5%CO2 and 95% air atmosphere. Two primary PDAC cell lines were freshly isolated from human pancreatic cancer tissues and were used between the third and fifth passage. Human Pancreatic stellate cells where isolated from pancreatic cancer tissues using the outgrowth method as described previously [18] .
Real-time quantitative polymerase chain reaction (QRT-PCR)
All reagents and equipment for mRNA and cDNA preparation were purchased from Roche (Roche Applied Science, Mannheim, Germany 
Wound healing assays
An artificial 'wound' was created using a 10-l pipette tip on confluent cell monolayers in 6-well culture plates as described previously [21] .
Quantification of 'wound' closure was carried out by counting the number of cells in the 'wound' area after 8 hrs and expressed as the average per three optical fields.
Anoikis assay
Cells were plated at a density of 1ϫ10 5 
In vivo tumour models
In vivo mouse tumourigenicity models and analysis of proliferation capacity and microvessel density of orthotopic tumours were performed using athymic Crl:NU/NU-Foxn1 nu (NU/NU) nude mice as described previously [20] . For the in vivo metastasis model, 1ϫ10 6 (Fig. 1A-3 ). Fig. 1C-3 ). None of the tested PDAC tissues (n ϭ 70) showed positive staining for moesin in the cancer cells (Fig. 1B-3 -5, 8) . In contrast, moesin was found to be abundant in the neoplastic cells of PAC (n ϭ 8) (Fig. 1B-6, 7) , which was also confirmed by confocal microscopy, demonstrating to some extent co-localization with actin ( Fig. 1B-9 ). We analysed one case of PAC with associated PanIN lesions [25] . Interestingly, anaplastic cancer cells demonstrated strong expression of moesin (Fig. 1C-1) , whereas PanIN lesions of the same tissue were generally negative for moesin (Fig. 1C-2 
Results
High expression of moesin in PAC and absent expression in PDAC
Characterization of ERM proteins in pancreatic tissues revealed strong expression of Ezrin in small ducts and centroacinar cells of the normal pancreas (Fig. 1A-1) and in cancer cells of PDAC (Fig. 1A-2). Ezrin was also present in some cells of PAC
Expression of radixin was observed in the cancer cells of PDAC and PAC tissues, but to a comparably lesser extent (Fig. 1A-4, 5). Expression of moesin was faintly detectable in normal pancreatic tissues (Fig. 1B-1) but present in fibroblasts/stellate cells and inflammatory cells of chronic pancreatitis (CP) tissues (Fig. 1B-2). Expression of moesin (and to a lesser extent of ezrin and radixin) in cultured pancreatic stellate cells as well as in peripheral blood mononuclear cells was also confirmed by QRT-PCR (
), except for the PanIN lesions with direct association to anaplastic cells (data not shown).
All eight tested pancreatic cancer cell lines strongly expressed moesin at the mRNA and protein level, and most of them also expressed ezrin and radixin (Fig. 1D) (Fig. 2D-1, 2) (Fig. 3A) . There were no significant relation between the expression of other EMT-related molecules and moesin expression in Panc-1 and SU8686 cell lines (Fig. 3A) . Since we did not observe a cadherin switch in moesin transfected Panc-1 and SU8686 cells, we analysed the expression pattern of ␤-catenin, as an important factor in EMT [27] . ␤-catenin displayed a membranous co-expression with moesin in wild-type and control transfected Panc-1 and SU8686 pancreatic cancer cells (Fig. 3B) . However, moesin RNAi transfected cells displayed reduced membranous localization of ␤-catenin (Fig. 3B) (Fig. 4A) . Differences in the expression of cellular moesin could also be confirmed by immunofluorescence confocal microscopy, where expression of moesin in Lv-MSN cells was below the level of detection (Fig. 4B) .
Since moesin has been implicated in metastatic activities of numerous malignancies [28] (Fig. 4C) .
Next, we investigated actin organization, upon serum starvation and 10 min. serum activation in the presence or absence of moesin using phalloidin staining of filamentous actin. Lv-control cells displayed apical actin organization, with the formation of cortical and transverse stress fibres (Fig. 4D-1) . Moreover, actin expression was associated with stably organized adherence junctions in these cells (Fig. 4D-2 (Fig. 4D-4) , which was related to disruption of adherence junction stability and formation of membrane protrusion and filopodia (Fig. 4D-5) . Furthermore, fluorescent staining of (Fig. 4D-3, 6 ). It is therefore likely that moesin-regulated migratory and adhesion changes of pancreatic cancer cells are promoted through cytoskeleton re-organization. (Fig. 5B-1, 2 ) and faint staining in Lv-MSN tumours (Fig. 5B-3-5) , as expected. Lv-control tumour cells displayed homogenous growth, with necrotizing areas within the tumour (Fig. 5B-1, 2) . In contrast, Lv-MSN tumours developed duct-like structures (Fig. 5B-3-5) . Quantification of proliferation and microvessel density of orthotopic tumours revealed significantly higher number of microvessels (Fig. 5C-1) and a higher proliferation index (Fig. 5C-2 (Fig. 5D-1-3 Fig. 6A-1) . In contrast, Lv-MSN tumours displayed well-developed and well-arranged ECM, with strong expression of fibronectin-1 in the basal parts of the ductlike structures (Fig. 6A-2) .
). Lv-MSN cells displayed strong accumulation of filamentous actin, with intense formation of cortical stress fibres
Fig. 1 High expression of moesin in PAC and loss of expression in PDAC. (A) Immunohistochemical staining of normal pancreas (1), PDAC (2) and PAC (3) samples using a specific ezrin antibody and of PDAC (4) and PAC (5) samples, using a specific radixin antibody (20ϫ magnification). (B) Immunohistochemical staining of normal pancreas (1), CP (2), PDAC (3-5) and PAC (6, 7) samples using a specific moesin monoclonal antibody (20ϫ magnification). Immunofluorescence confocal microscopy staining of PDAC (8) and PAC (9) tissues using the moesin antibody (red). Note actin (green), and nuclear (blue) DAPI counterstaining. (C) Immunohistochemical staining of PAC (1) containing PanIN lesions (2) with a specific moesin antibody (20ϫ magnification). (3) QRT-PCR data of ezrin/radixin/moesin expression in pancreatic stellate cells (PSC) and peripheral blood mononuclear cells (PBMC). (D) QRT-PCR showing expression of ezrin/radixin/moesin (left panel), and immunoblot analysis showing expression of ezrin/radixin/moesin in eight cultured pancreatic cancer cell lines (right panel), as well as in two primary pancreatic cancer cell lines (pPDAC1; pPDAC2; lower panel).
Fig. 2 Moesin promotes adhesion and reduces invasion and migration. (A) Immunoblot showing transient down-regulation of moesin in Panc1 and
focal adhesions of Lv-MSN cells revealed increased co-localization with actin fibres compared to Lv-control cells
Expression of moesin results in an 'anaplastic pattern of growth' of PDAC cells
In vivo, subcutaneous nude mouse tumours appeared earlier and grew faster in the Lv-MSN group compared to Lv-controls
). In contrast, neither gross nor micrometastases were found in Lv-control injected mice (n ϭ 3), suggesting a comparably lower metastatic activity of moesin expressing pancreatic cancer cells. For better evaluation of the growth differences of Lv-MSN and Lv-control tumours, we next analysed the distribution of the extracellular matrix (ECM) in in vivo grown tumours. Lv-control tumours demonstrated a poorly organized ECM, with weak expression of fibronectin-1 (
Next, we analysed ␤-catenin, E-cadherin and N-cadherin distribution in Lv-MSN and Lv-control orthotopic tumours. Lv-control tumours displayed a more organized pattern of ␤-catenin expression (Fig. 6B-1) than tumours of Lv-MSN, where ␤-catenin distribution was cytoplasmic throughout the tumour tissue ( Fig. 6B-2) . In contrast, there was no difference in the expression and distribution of E-cadherin between Lv-control and Lv-MSN tumours (Fig. 6B-3, 4) . In line with the in vitro results, we found strong expression of N-cadherin in all Lv-control tumours (Fig. 6B-5) , and down-regulation in Lv-MSN tumour tissues (Fig. 6B-6 (Fig. 7) . These characteristics closely resemble the morphology of PAC (Fig. 7) 
Discussion
Moesin, a member of the ERM protein family, is involved in the association of the plasma membrane with the actin component of the cytoskeleton [6] and was preliminary isolated as a heparinbinding protein [29] . A conformational change induced by phosphorylation results in the active form of the protein [30] , which binds actin and cell-type-dependent transmembrane proteins, such as CD44, CD43 and several I-CAMs [6] and, is thus involved in the pathogenesis of different malignancies. The expression and localization of ␤-catenin strongly influences cytoskeleton reorganization during pancreatic tumourigenesis [27, 31, 32] . In this study, we demonstrated that ␤-catenin is co-expressed with moesin at the cell membrane and that silencing of moesin leads to cytoplasmic translocation of this protein.
Membranous stabilization of ␤-catenin contributes to tumour suppression [31] , therefore it could be hypothesized that expression of moesin reduces invasion of pancreatic cancer cells via maintaining membranous localization of ␤-catenin.
Expression of moesin has been suggested as a prognostic factor for different types of malignancies [28, 33, 34] , and has previously also been evaluated in PDAC tissues [14] . In line with our observation, the published figures [14] (1, 2) and Lv-MSN (3) (4) (5) (3, 4) and Ncadherin (5, 6) 
